REXVIQUE Trademark

Trademark Overview


On Wednesday, September 29, 2021, a trademark application was filed for REXVIQUE with the United States Patent and Trademark Office. The USPTO has given the REXVIQUE trademark a serial number of 97052212. The federal status of this trademark filing is REGISTERED as of Tuesday, January 24, 2023. This trademark is owned by GlaxoSmithKline Biologicals SA. The REXVIQUE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
rexvique

General Information


Serial Number97052212
Word MarkREXVIQUE
Filing DateWednesday, September 29, 2021
Status700 - REGISTERED
Status DateTuesday, January 24, 2023
Registration Number6960646
Registration DateTuesday, January 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Tuesday, January 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 5, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 30, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 12, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, September 12, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, August 30, 2022WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Monday, August 29, 2022ASSIGNED TO PETITION STAFF
Thursday, August 11, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022ASSIGNED TO EXAMINER
Wednesday, October 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 2, 2021NEW APPLICATION ENTERED